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Introduction
Colorectal cancer is a common disease. According to the Minis-
try of Health, Labour and Welfare, cancer has been the most
common cause of death in Japan since 2013; colorectal cancer
is the most frequent cause of cancer-related death in women.
Colonoscopy plays a critical role in the early detection and
treatment of colorectal cancer [1, 2].
Oral polyethylene glycol (PEG) is the most popular means of
preparing the bowel for colonoscopy in Japan, but magnesium
citrate (MC) and sodium phosphate (sodium dihydrogen phos-
phate monohydrate/sodium dihydrogen phosphate anhydrous)
are also widely used. Oral bowel preparation for colonoscopy is
associated with potential adverse events [3].
Many studies have reported adverse events (AEs) associated
with colonoscopy, but most have focused on those caused by
the conduct of colonoscopy or by endoscopic treatment of the
abnormalities detected rather than those caused by bowel
preparation for colonoscopy [4].
The most severe AEs associated with oral bowel preparation
are large bowel obstruction (LBO) and perforation [5]. Acute,
complete LBO requires emergency abdominal surgery, and is
associated with high morbidity and mortality rates if left un-
treated.
Retrospective analysis of large bowel obstruction or perforation
caused by oral preparation for colonoscopy
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ABSTRACT
Background and study aims Patients undergoing bowel
preparation for colonoscopy are at risk of potentially severe
adverse events such as large-bowel obstruction (LBO) and
perforation. These patients usually need emergency sur-
gery and the consequences may be fatal. Little is known
about the risk factors for LBO and perforation in these cir-
cumstances. We sought to establish the natural history of
LBO and perforation caused by oral preparation for colonos-
copy.
Patients and methods We retrospectively analyzed data
from 20 patients with LBO or perforation associated with
oral preparation for colonoscopy. All patients were treated
at the Showa University Northern Yokohama Hospital
(SUNYH) between April 2001 and December 2015. Drugs
used for bowel preparation, age, sex, indication for colo-
noscopy, pathogenesis and treatment were recorded.
Results Eighteen of the patients had LBO and 2 had per-
foration. Fourteen events occurred at SUNYH, which
accounted for 0.016% of patients who underwent bowel
preparation during this period. Seventeen patients were
symptomatic when the decision to undertake colonosco-
py was made (including 7 who complained of constipa-
tion and 4 who complained of abdominal pain; 3e were
asymptomatic). Nineteen patients ultimately required
surgery, 13 within 3 days of presentation. Eleven pa-
tients ultimately required colostomy. There was no perio-
perative mortality in our cases.
Conclusion Large bowel obstruction and perforation are
rare events associated with oral preparation for colonos-
copy, but frequently require surgery. Exacerbation of
constipation might be a risk factor for LBO or perfora-
tion. Potentially catastrophic situations can be avoided
by early detection and treatment.
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In September 2003, an emergency safety bulletin was issued
by the Ministry of Health, Labour and Welfare in Japan high-
lighting the risks of LBO and perforation caused by oral bowel
preparation for colonoscopy [6]. According to this bulletin,
LBO occurred in 7 patients between July 1993 and September
2003 (1of whom died [14.3%]) and perforation occurred in 11
patients (5 of whom died [45.5%]).
This report had a profound impact on routine clinical prac-
tice in Japan. When a patient had severe constipation or stand-
ard preparation was suboptimal, we always used additional
preparation. Nevertheless, the risk of LBO or perforation may
be elevated by the use of additional bowel preparation drugs.
Consequently, clinicians must have a high index of suspicion
that complications might arise in patients with severe constipa-
tion, or in whom bowel preparation is inadequate with standard
techniques.
But it contained no scientific analysis of the likely pathogen-
esis of the adverse events documented. Consequently, the risk
factors for LBO and perforation during bowel preparation for
colonoscopy are not fully understood. We undertook a retro-
spective analysis of patients who had developed LBO or a bowel
perforation associated with oral preparation drugs, to inform
the development of a suite of preventive measures for patients
undergoing colonoscopy. We sought to clarify the causes and
risk factors for LBO and perforation.
Patients and methods
We undertook a retrospective analysis of patients’ clinical re-
cords at Showa University Northern Yokohama Hospital (SU-
NYH), Japan. The subjects of the study were patients of SUNYH
treated between April 2001 and December 2015, who were di-
agnosed with LBO or perforation caused by oral drugs for bowel
preparation.
We recorded the following for each patient: age, sex, indica-
tions for colonoscopy, preparation drug or drugs used, location
of LBO/perforation, pathogenesis, requirement for surgery, re-
quirement for emergency surgery, requirement for colostomy
and mortality. From these data, we analyzed the pathogenesis
of LBO and perforation, and we propose prophylactic measures
for the prevention of these AEs.
Results
We identified 20 patients (13 men and 7 women) diagnosed
with LBO or perforation associated with oral bowel preparation
drugs, who were treated at SUNYH in the study period. Four-
teen cases underwent colonoscopy at SUNYH, while six occurr-
ed at other hospitals and were referred to SUNYH for treat-
ment. The frequency of LBO or perforation associated with
oral bowel preparation at SUNYH was 0.016% (14 out of
86,463 colonoscopies).
Among the 14 patients of SUNYH, 12 were diagnosed with
LBO and two were diagnosed with perforation. A representative
case of bowel perforation is illustrated in ▶Fig. 1.
▶Table1 shows the demographic and clinical details of the
cohort. The mean age was 64.9 years (± standard deviation 12.4
years). The mean duration of symptoms before colonoscopy
was undertaken was 70.7±92.4 days; 8 patients had presented
with constipation, 6 with abdominal pain and 2 with anorexia; 3
were asymptomatic.
The drug used for bowel preparation was PEG in 15 cases and
MC in 1 case; 1 patient was given both, 2 were given sodium pi-
cosulfate hydrate (SPH) and 1 patient was given SPH and MC
the day before colonoscopy.
The cause of the AE was judged to be advanced cancer in 18
patients, transverse colon stenosis resulting from inflammation
that had spread from an inflamed gallbladder in 1 patient, and
bowel obstruction by feces in 1 patient.
For patients with cancer, the mean maximum tumor diame-
ter was 55.6 ±21.8mm. The tumor was situated in the sigmoid
colon in 10 patients, the rectum in 4 patients, the transverse
colon in 2 patients and the ascending colon in 2 patients. All pa-
tients with perforation underwent urgent surgery. Patients
with LBO were treated in 1 of 3 ways: urgent surgery within 3
days (8 patients); elective surgery (3 patients); or decompres-
sion by placement of a long intestinal tube (LIT) or self-expand-
ing metallic stent (SEMS) followed by surgery (7 patients; 5 had
a LIT and 2 a SEMS). Nineteen patients required surgery; 11
(57.9%) required a colostomy. There was no perioperative mor-
tality.
We have used a strategic protocol for colonoscopy prepara-
tion since 2004 (▶Fig. 2), to prevent LBO and perforation. A de-
tailed history of defecation status during preparation taken by
specialist endoscopy nurses can contribute to early prevention
and detection of AEs. After we started using the protocol, the
incidence of AEs was reduced from 0.044% (2001–2003, 4 out
of 9,175 patients) to 0.013% (2004–2015 10 out of 77,288 pa-
tients). This difference was not statistically significant (P=
▶ Fig. 1 A representative case of a patient with large bowel per-
foration. The reported symptom at the first hospital visit was nar-
rowing of the stool. There had been defecation on the day of ex-
amination. The patient drank 2800mL polyethylene glycol and de-
fecated 7 times, and subsequently reported sudden-onset abdomi-
nal pain and cold sweats. We performed computed tomography
and confirmed the presence of free air, ascites and rectal cancer.
Emergency surgery was undertaken and at laparotomy, a large
amount of intraperitoneal stool was present.
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0.053), but might suggest the presence of a trend towards few-
er AEs since introduction of the protocol (P<0.05 was consid-
ered significant).
Discussion
Large bowel obstruction and perforation associated with oral
preparation for colonoscopy are rare, but they can be fatal
and, thus, require early recognition and prompt treatment.
AEs that have been reported include: Mallory-Weiss syn-
drome and esophageal perforation caused by vomiting [7–
10]; acute respiratory distress syndrome caused by aspiration
pneumonia [11]; allergy and anaphylactic shock [12–14]; hy-
perphosphatemia [15, 16] and ischemic colitis caused by peror-
al preparation drugs [17–19]. There have also been a few re-
ports of LBO and perforation caused by bowel preparation. [5]
A previous report of bowel perforation in 2 patients (1 of whom
died from colon perforation caused by colorectal cancer, the
other underwent emergency colostomy) suggested that use of
magnesium sulfate, an osmotic laxative that creates hypertonic
pressure in the intestine after oral administration, might have
contributed. [5] Magnesium sulfate prevents water reabsorp-
tion, mechanically stimulates intestinal peristalsis and facili-
tates bowel movement, thereby softening the stool and cleans-
ing the intestinal tract. In this case, it was judged that magne-
sium sulfate had increased the intraluminal pressure of the ob-
structed colon until it ruptured.
Ours was a retrospective review of patients with LBO or per-
foration. In both cases of perforation, PEG was used. Although
PEG is excreted in the feces without disturbing serum and urin-
ary electrolyte concentrations or urine volume, it nonetheless
increases intraluminal pressure in the intestinal tract. As with
the reported cases with magnesium sulfate, we judge increased
pressure within the intestine – and the presence of a vulnerable
lesion – to have been the cause of bowel perforation on our co-
hort.
The preparation strategy outlined in ▶Fig. 2 also informs
clinical decision-making and ensures patient safety. Prompt
use of imaging, administration of enemas and adjustment of
drug doses can mitigate against precipitous increases in intes-
tinal pressure, and contributes to the early detection and man-
agement of LBO and perforation.
In addition, LBO and perforation rarely occur in the absence
of malignancy. We should pay attention to the cases if the exis-
tence of malignant tumor is known or strongly suspected by
previous doctor's introduction, computed tomography (CT) or
high tumor marker.
In LBO and perforation caused by cancer cases, 11 cases
(61%) had increased levels of the tumor maker carcinoem-
bryonic antigen (CEA). The average was 43.9ng/mL. Seven pa-
tients had CEA levels less than 5ng/mL. About LBO or perfora-
tion cases, even though it is difficult to predict LBO or perfora-
tion, it may have been possible to suspect the presence of a
tumor in more than half the cases.
We also judge exacerbation of constipation to be a risk fac-
tor for bowel perforation, given that 7 patients who subse-
quently developed LBO had initially presented with disturbance
of bowel movement. Indeed, a total of 12 patients had reported
abnormal bowel movement if stool narrowing and diarrhea
were included, both of which may accompany severe constipa-
tion. Both patients with perforation presented with stool nar-
rowing, not constipation.
Strict confirmation of the defecation state before bowel
preparation may have the potential to avert AEs. In routine clin-
ical practice, we attempt to diagnose AEs as promptly as possi-
ble using imaging tests such as x-ray and CT if patients report
lack of defecation and abdominal symptoms after bowel prepa-
ration has been administered. Nevertheless, it is not possible to
prevent all AEs, as some occur with sudden onset and some pa-
tients are asymptomatic when the decision to undertake colo-
noscopy is made. An appreciation of the risks of oral prepara-
tion for colonoscopy and a high index of suspicion among
healthcare professionals can ensure that AEs are detected and
treated promptly to avoid the need for surgery and to prevent
deaths.
In 8 patients in our cohort large tumors had been identified
on CT before colon preparation. We suggest that non-oral bow-
el preparation should be used (for example, glycerin enema)
when massive tumors are detected before colonoscopy.
Patients’ medical history and serum albumin concentrations
are presented in ▶Table2. The mean serum albumin concen-
tration was 3.7g/dL. Hypoalbuminemia (serum albumin
concentration <3.8g/dL) was evident in 11 cases (61.1%).
Mean body mass index (BMI) was 21.0 kg/m2, and was below
18.5 kg/m2 in 4 cases (22.2%). Three patients (16.7%) were
found to have colonic diverticular disease. We judge that nutri-
Defecation on the day before colonoscopy
Half PEG CT
Caution case Treatment
LIT
SEMS
Surgery
Half PEG (1 L)
–
–
– +
–
Defecation
Suspect of bowel 
obstruction of 
perforation
Defecation
+
+
+ GE 60 ml or 120 ml
▶ Fig. 2 Strategy for colonoscopy preparation at the Showa Uni-
versity Northern Yokohama Hospital for preventing bowel obstruc-
tion and perforation. Caution case means Conservative manage-
ment and observation. PEG, polyethylene glycol; CT, computed to-
mography; GE, glycerin enema; LIT, long intestinal tube; SEMS, self-
expandable metallic stent.
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tional condition, colonic diverticular disease and BMI did not
strongly influence our findings. The number of control groups
was too large, it was difficult to evaluate the risk factor of this
study, and it became a one arm evaluation. In future, larger,
prospective observational or retrospective case-controlled
studies may help to illuminate the risk factors for LBO and per-
foration.
Conclusion
In conclusion, LBO and perforation associated with an oral
preparation for colonoscopy are rare, but can have severe con-
sequences. LOB or perforation cannot accurately be predicted
from bowel habit and abdominal findings alone. Potentially cat-
astrophic situations can be avoided by early detection and
treatment. All staff working in endoscopy units should have an
appreciation of the adverse events associated with preparation
for colonoscopy.
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